athenahealth (NASDAQ:ATHN) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday.

Other equities research analysts have also issued research reports about the stock. Oppenheimer reaffirmed a “buy” rating and set a $184.00 target price on shares of athenahealth in a research note on Friday, October 20th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $167.00 target price on shares of athenahealth in a research note on Tuesday, October 17th. SunTrust Banks reaffirmed a “buy” rating and set a $156.00 target price on shares of athenahealth in a research note on Wednesday, October 25th. KeyCorp reaffirmed a “buy” rating and set a $152.00 target price on shares of athenahealth in a research note on Friday. Finally, TheStreet lowered shares of athenahealth from a “b-” rating to a “c+” rating in a research note on Wednesday, October 11th. Two analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and nine have given a buy rating to the company. athenahealth has an average rating of “Hold” and a consensus target price of $143.96.

athenahealth (ATHN) traded down $1.26 during mid-day trading on Tuesday, hitting $128.21. 644,776 shares of the company’s stock were exchanged, compared to its average volume of 347,832. athenahealth has a 12-month low of $95.01 and a 12-month high of $158.66. The stock has a market capitalization of $5,130.00, a PE ratio of 166.51, a price-to-earnings-growth ratio of 3.03 and a beta of 1.58. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.67 and a quick ratio of 1.67.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The firm had revenue of $304.60 million for the quarter, compared to analysts’ expectations of $310.52 million. During the same quarter in the previous year, the company earned $0.60 earnings per share. The company’s revenue for the quarter was up 10.1% compared to the same quarter last year. research analysts expect that athenahealth will post 1.22 EPS for the current fiscal year.

In other news, SVP Bradford Kyle Armbrester sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, October 27th. The shares were sold at an average price of $128.56, for a total value of $128,560.00. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Amy Abernethy sold 500 shares of the company’s stock in a transaction that occurred on Tuesday, December 26th. The stock was sold at an average price of $134.18, for a total transaction of $67,090.00. Following the completion of the transaction, the director now owns 4,045 shares in the company, valued at approximately $542,758.10. The disclosure for this sale can be found here. In the last quarter, insiders sold 69,700 shares of company stock worth $9,375,172. Insiders own 3.20% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of ATHN. The Manufacturers Life Insurance Company raised its holdings in shares of athenahealth by 7.7% during the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after purchasing an additional 84 shares during the last quarter. BNP Paribas Arbitrage SA raised its holdings in shares of athenahealth by 123.8% during the second quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock valued at $189,000 after purchasing an additional 744 shares during the last quarter. ProShare Advisors LLC purchased a new position in shares of athenahealth during the second quarter valued at approximately $205,000. Ameriprise Financial Inc. purchased a new position in shares of athenahealth during the second quarter valued at approximately $206,000. Finally, Columbia Partners L L C Investment Management purchased a new position in shares of athenahealth during the second quarter valued at approximately $216,000.

TRADEMARK VIOLATION WARNING: This article was originally published by Watch List News and is the property of of Watch List News. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://www.watchlistnews.com/athenahealth-athn-downgraded-to-sell-at-bidaskclub/1809886.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.